Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors
2017 · Molecular Therapy — Oncolytics · 44 citations
https://doi.org/10.1016/j.omto.2017.05.005
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
1.1K
Citations
14
h-index
17
i10-index
Adam Studebaker is an academic researcher from Nationwide Children's Hospital. The author has contributed to research in topics: PI3K/AKT/mTOR signaling in cancer & Melanoma and MAPK Pathways & Synthesis and biological activity. The author has an h-index of 14, co-authored 62 publications.
https://doi.org/10.1016/j.omto.2017.05.005
https://doi.org/10.1038/srep09248
Click to start Chat